Not logged in...
About USC Norris
Research
Patient Care
CISO
Search Trials
FAQ - Trials
Contact Us - Trials
Membership
Education
Shared Resources
Support USC Norris
Outreach
Login/Logout
Contact USC Norris
Support Us
Donate
Menu
USC Norris
»
Clinical Trials
Trial NC-HEM-16-1
A Phase 1/2 Open-Label, Dose Escalation Study of PRTX-100 in Adult Patients with Persistent/Chronic Immune Thrombocytopenia
Type:
Treatment
Phase:
Phase I/II
Status:
Not Open (Closed)
Treatments:
Immunomodulator
Randomized:
No
USC Satellite Location:
None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
Howard Liebman, M.D.
Other Trial Staff:
Christine Duran, Coordinator, Ibrahim Syed, Coordinator
Staff may
log in
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.